Selinexor in Combination with Cladribine, Cytarabine and G-CSF for Relapsed or Refractory AML

被引：0
|
作者：
Uy, Geoffrey L.
Rettig, Michael P.
Fletcher, Theresa
Riedell, Peter A.
Stockerl-Goldstein, Keith E.
Ghobadi, Armin
Jacoby, Meagan
Cashen, Amanda F.
Romee, Rizwan
Pusic, Iskra
Abboud, Camille N.
Schroeder, Mark A.
Vij, Ravi
Westervelt, Peter
DiPersio, John F.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
816
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Treatment of resistant or relapsed AML and MDS with the combination of G-CSF, cyclosporin, idarubicin and cytarabine
    Smeets, M
    Raymakers, R
    Vierwinden, G
    Linssen, P
    Muus, P
    De Witte, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 222 - 222
  • [2] Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemia
    Robak, T
    Wrzesien-Kus, A
    Lech-Maranda, E
    Kowal, M
    Dmoszynska, A
    LEUKEMIA & LYMPHOMA, 2000, 39 (1-2) : 121 - 129
  • [3] Phase 2 Study of 5 Days Azacytidine Priming Prior to Fludarabine, Cytarabine and G-CSF Combination for Patients with Relapsed or Refractory AML
    Motabi, Ibraheem H.
    Iqbal, Shahid
    Zaidi, Syed Ziauddin A.
    Albtoosh, Belal
    Alshehry, Nawal Faiez
    AlGhamdi, Mubarak S.
    Tailor, Imran Khan
    Altaf, Syed
    BLOOD, 2018, 132
  • [4] Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia
    Abboud, Ramzi
    Chendamarai, Ezhilarasi
    Rettig, Michael P.
    Trinkaus, Kathryn M.
    Riedell, Peter A.
    Abboud, Camille N.
    Ghobadi, Armin
    Pusic, Iskra
    Stockerl-Goldstein, Keith
    Schroeder, Mark A.
    Vij, Ravi
    Westervelt, Peter
    DiPersio, John F.
    Uy, Geoffrey L.
    HAEMATOLOGICA, 2020, 105 (08) : E404 - E407
  • [5] G-CSF Priming, Clofarabine and High Dose Cytarabine (GCLAC) for Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Storer, Barry E.
    Appelbaum, Frederick R.
    BLOOD, 2009, 114 (22) : 816 - 816
  • [6] The Efficacy and Safety of Cladribine in Combination with Cytarabine,ATRA, G-CSF and Mitoxantrone(Claag-M Regimen)in Relapsed/Refractory AML : A Phase 1/2, Prospective, Single-Arm, Multicenter Study
    Zhang, Tinghua
    Xie, Yinghua
    Zhao, Limin
    Han, Xiyao
    Lu, Yingting
    Zhang, Jing
    Xie, Yanhui
    Zhu, Qi
    Sun, Lihua
    Yang, Li
    Liu, Ligen
    BLOOD, 2019, 134
  • [7] CHAG priming regimen containing of cytarabine, aclacinomycin homoharringtonine and G-CSF for relapsed refractory acute myelogenous Leukemia: a modified combination chemotherapeutic combination
    Chen, Lin
    Yin, Qingsong
    Mi, Ruihua
    Wei, Xudong
    LEUKEMIA & LYMPHOMA, 2013, 54 (10) : 2291 - 2293
  • [8] Phase I Study of Cladribine (2-chlorodeoxyadenosie), Cytarabine and G-CSF Based Induction Therapy (CLAG) with ATRA (All-trans retinoic acid) and Midostaurin for Relapsed/Refractory AML
    Ramsingh, Giridharan
    Sprau, Andrew
    Westervelt, Peter
    McBride, Ali
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    Uy, Geoffrey L.
    Cashen, Amanda
    DiPersio, John F.
    Abboud, Camille N.
    BLOOD, 2011, 118 (21) : 1541 - 1542
  • [9] Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia
    Cui, Tong
    Li, Huiyu
    Zhou, Shiyuan
    Li, Jing
    Zhu, Qian
    Zhu, Wenjuan
    Tang, Zaixiang
    Ma, Xiao
    Qiu, Huiying
    Wu, Depei
    Wu, Xiaojin
    ANNALS OF HEMATOLOGY, 2024, 103 (07) : 2463 - 2473
  • [10] Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia
    Chen, Xiaomei
    Weng, Jianyu
    Wang, Yulian
    Deng, Chengxin
    Luo, Chengwei
    Liao, Pengjun
    Li, Minming
    Huang, Xin
    Lai, Peilong
    Huang, Lisi
    Cao, Zhi
    Wan, Changchun
    Zhong, Liye
    Wu, Suijing
    Lu, Zesheng
    Zou, Xiaoli
    Du, Xin
    BLOOD, 2015, 126 (23)
12345